Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection

Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection

Pyoderma gangrenosum (PG) is a rare and chronic neutrophil inflammation belonging to the spectrum of autoinflammatory disorders. Immunosuppressive therapy is the cornerstone of successful treatment. However, due to the global COVID-19 pandemic, physicians struggle with therapeutic strategies during...

Full description

Bibliographic Details
Main Authors: Marcella Ricardis May, Albert Rübben, Andrea Lennertz, Luk Vanstreels, Marike Leijs
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Journal of Personalized Medicine
Subjects:
COVID-19
pyoderma gangrenosum
immunosuppression
cyclosporine
corticosteroids
autoinflammatory disease
Online Access:https://www.mdpi.com/2075-4426/12/2/173

Internet

https://www.mdpi.com/2075-4426/12/2/173

Similar Items